DJIA 17,810.06 91.06 0.51%
NASDAQ 4,712.97 11.10 0.24%
S&P 500 2,063.50 10.75 0.52%
market minute promo


company name or ticker

5 Things Actavis plc's Management Wants You to Know

Specialty and generic drugmaker Actavis plc reported another monster quarter last week. Here are five things management wants investors to know going forward.

Earnings Triple Plays

Bill Ackman vs. Allergan, Inc.: Who Will Win the War of Words?

Valeant Pharmaceuticals' takeover bid for Allergan has turned hostile in more ways than one.

Scott Black's Top 5 Holdings in the Third Quarter

Actavis (ACT) Upgraded From Hold to Buy

Bulls Rule As Volatility Recedes And Investors Position For Holiday Cheer

A Look at the Top Five Medical Stocks Held in the Vanguard Portfolio

3 Stocks Dragging In The Drugs Industry

2 Biotech Stocks to Buy After Earnings

Comparing America's 3 Largest Generic Drugs Companies

See More Articles...